Cita APA

Fujihara, K., & Nakashima, I. (2014). Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? Lippincott Williams & Wilkins.

Chicago Style Citation

Fujihara, Kazuo, i Ichiro Nakashima. Secondary Progression and Innate Immunity in NMO: A Possible Link to Alemtuzumab Therapy? Lippincott Williams & Wilkins, 2014.

Cita MLA

Fujihara, Kazuo, i Ichiro Nakashima. Secondary Progression and Innate Immunity in NMO: A Possible Link to Alemtuzumab Therapy? Lippincott Williams & Wilkins, 2014.